RecruitingNot applicableNCT07090226

Diffuse Cutaneous Scleroderma (DSSc) SFDI Study

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Boston University
Principal Investigator
Andreea Bujor, MD, PhD
BU Chobanian & Advesian School of Medicine
Intervention
Spatial-frequency domain imaging (SFDI)(other)
Enrollment
65 enrolled
Eligibility
18 years · All sexes
Timeline
20252028

Study locations (1)

Collaborators

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07090226 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis

← Back to all trials